Pharvaris (PHVS) Selling, General & Administrative (2020 - 2026)
Powered by 
Analysis
Pharvaris (PHVS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Pharvaris | 2.14 Bn | 1.77 Bn | 85,072.10 | -18.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.35 Mn |
| Mar 31, 2026 | -16.52 Mn |
| Dec 31, 2025 | -15.67 Mn |
| Sep 30, 2025 | -11.51 Mn |
| Jun 30, 2025 | -12.19 Mn |
| Mar 31, 2025 | -11.86 Mn |
| Dec 31, 2024 | -14.85 Mn |
| Sep 30, 2024 | -13.31 Mn |
| Jun 30, 2024 | -12.18 Mn |
| Mar 31, 2024 | -10.65 Mn |
| Dec 31, 2023 | -9.22 Mn |
| Sep 30, 2023 | -8.34 Mn |
| Jun 30, 2023 | -8,464.68 Bn |
| Mar 31, 2023 | -7.87 Mn |
| Dec 31, 2022 | -7.67 Mn |
| Sep 30, 2022 | -8.37 Mn |
| Jun 30, 2022 | -8,173.80 Bn |
| Mar 31, 2022 | -6.58 Mn |
| Dec 31, 2021 | -6.34 Mn |
| Sep 30, 2021 | -5.16 Mn |